-+ 0.00%
-+ 0.00%
-+ 0.00%

CREATIVE MEDICAL TECHNOLOGY HOLDINGS REACHES MAJOR CLINICAL INFLECTION POINT WITH POSITIVE INTERIM DATA FROM ADAPT TRIAL AND CELZ-201 (OLASTROCEL) IN THE TREATMENT OF CHRONIC LOWER BACK PAIN

Reuters·01/13/2026 14:15:00

Please log in to view news